These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24905374)

  • 41. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
    Bonnet U; Mahler H
    Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. "Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use.
    Kasick DP; McKnight CA; Klisovic E
    Am J Drug Alcohol Abuse; 2012 Mar; 38(2):176-80. PubMed ID: 22221190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Designer drugs and caffeine - characteristics of psychoactive substances and their impact on the organism].
    Wierzejska R
    Dev Period Med; 2014; 18(3):394-9. PubMed ID: 25182406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ["Legal highs" from the German internet--"bath salt drugs" on the rise].
    Musshoff F; Hottmann L; Hess C; Madea B
    Arch Kriminol; 2013; 232(3-4):91-103. PubMed ID: 24358620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Occurrence of the use of designer drugs in Poland--review of the published evidence.
    Kryska S
    Przegl Epidemiol; 2016; 70(1):35-9, 121-3. PubMed ID: 27344472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthetic drugs: bath salts and spice.
    Randolph SA
    Workplace Health Saf; 2014 Feb; 62(2):88. PubMed ID: 24512723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of drugs of abuse on social behaviour: a review of animal models.
    Blanco-Gandía MC; Mateos-García A; García-Pardo MP; Montagud-Romero S; Rodríguez-Arias M; Miñarro J; Aguilar MA
    Behav Pharmacol; 2015 Sep; 26(6):541-70. PubMed ID: 26221831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal.
    Cooper ZD
    Curr Psychiatry Rep; 2016 May; 18(5):52. PubMed ID: 27074934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug abuse: newly-emerging drugs and trends.
    Davis GG
    Clin Lab Med; 2012 Sep; 32(3):407-14. PubMed ID: 22939299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Survey of current trends in the abuse of psychotropic substances and plants in Japan.
    Kikura-Hanajiri R; Uchiyama N; Goda Y
    Leg Med (Tokyo); 2011 May; 13(3):109-15. PubMed ID: 21377397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research chemicals marketed as legal highs: the case of pipradrol derivatives.
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jul; 212(1):57-60. PubMed ID: 22564760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Points & Pearls: Cannabinoids: emerging evidence in use and abuse.
    Williams MV; Gupta N; Nusbaum J
    Emerg Med Pract; 2018 Aug; 20(Suppl 8):1-2. PubMed ID: 30070813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and pharmacological aspects of bath salt use: a review of the literature and case reports.
    Miotto K; Striebel J; Cho AK; Wang C
    Drug Alcohol Depend; 2013 Sep; 132(1-2):1-12. PubMed ID: 23916320
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents.
    Warren KE; Tay S; Wen LS
    J Adolesc Health; 2017 May; 60(5):483-486. PubMed ID: 28433118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic cannabinoids and "bath salts" should be considered drugs of abuse.
    Penders T; Saeed S
    Am Fam Physician; 2012 May; 85(9):852. PubMed ID: 22612177
    [No Abstract]   [Full Text] [Related]  

  • 59. Investigating the 'bath salt' panic: the rarity of synthetic cathinone use among students in the United States.
    Stogner JM; Miller BL
    Drug Alcohol Rev; 2013 Sep; 32(5):545-9. PubMed ID: 23718639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Psychoactive drug abuse in older adults.
    Simoni-Wastila L; Yang HK
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.